Myostatin as a plausible biomarker for early stage of sarcopenic obesity

MLA

Chisaki Ishibashi, et al. “Myostatin as a Plausible Biomarker for Early Stage of Sarcopenic Obesity.” Scientific Reports, vol. 14, no. 1, Nov. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1038/s41598-024-79534-5.

APA

Chisaki Ishibashi, Kaori Nakanishi, Makoto Nishida, Haruki Shinomiya, Maki Shinzawa, Daisuke Kanayama, Ryohei Yamamoto, Takashi Kudo, Izumi Nagatomo, & Keiko Yamauchi-Takihara. (2024). Myostatin as a plausible biomarker for early stage of sarcopenic obesity. Scientific Reports, 14(1), 1–10. https://doi.org/10.1038/s41598-024-79534-5

Chicago

Chisaki Ishibashi, Kaori Nakanishi, Makoto Nishida, Haruki Shinomiya, Maki Shinzawa, Daisuke Kanayama, Ryohei Yamamoto, Takashi Kudo, Izumi Nagatomo, and Keiko Yamauchi-Takihara. 2024. “Myostatin as a Plausible Biomarker for Early Stage of Sarcopenic Obesity.” Scientific Reports 14 (1): 1–10. doi:10.1038/s41598-024-79534-5.